Technology: Cell therapy, Cell-based gene therapy
Industry: Private
Headquarters: Berkeley, California, United States
Founded Date: 2018-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 13
Total Funding: 110000000
Estimated Revenue: Less than $1M
Last Funding Date: 2022-01-26
Last Funding Type: Series B

Visit Website
info@kyvernatx.com
Register and Claim Ownership